Evercore Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $75
Evercore analyst Liisa Bayko maintains $Insmed(INSM.US)$ with a buy rating, and maintains the target price at $75.According to TipRanks data, the analyst has a success rate of 45.1% and a total
Insmed Incorporated (INSM) Surged Following Positive Data For Its Drug
Barclays Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $90
Barclays analyst Leon Wang maintains $Insmed(INSM.US)$ with a buy rating, and maintains the target price at $90.According to TipRanks data, the analyst has a success rate of 71.4% and a total
Barclays Sticks to Their Buy Rating for Insmed (INSM)
Insmed(INSM.US) Officer Sells US$10.61 Million in Common Stock
$Insmed(INSM.US)$ Officer Flammer Martina M.D. sold 149K shares of common stock on Sep 6, 2024 at an average price of $71.23 for a total value of $10.61 million.Source: Announcement What is
Here's How Much $1000 Invested In Insmed 10 Years Ago Would Be Worth Today